Dataset Information
The use of polyphenols extracted from Chinese sweet leaf tea (Rubus suavissimus S. Lee.) as novel drugs for the treatment of metabolic dysfunction associated steatotic liver disease.
Ontology highlight
ABSTRACT:
SUBMITTER: Pan Y
PROVIDER: S-EPMC12291371 | biostudies-literature | 2025 Jul
REPOSITORIES: biostudies-literature
Publications
The use of polyphenols extracted from Chinese sweet leaf tea (Rubus suavissimus S. Lee.) as novel drugs for the treatment of metabolic dysfunction associated steatotic liver disease.
Hereditas 20250724 1
BACKGROUND: Metabolic dysfunction associated steatotic liver disease (MASLD) is a pressing global health issue with limited treatment options. Chinese sweet leaf tea (CSLT), rich in polyphenols, shows promise in addressing MASLD due to its anti-inflammatory, obesity-reducing, and metabolic-regulating properties. This study aimed to explore the therapeutic potential of CSLT polyphenols for MASLD treatment. METHODS: A comprehensive approach combining bioinformatics, network pharmacology, molecular ...[more]